Invention Grant
US08211922B2 1-methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities
有权
1-甲基烟酰胺衍生物和用于治疗脂蛋白异常的制剂
- Patent Title: 1-methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities
- Patent Title (中): 1-甲基烟酰胺衍生物和用于治疗脂蛋白异常的制剂
-
Application No.: US12690797Application Date: 2010-01-20
-
Publication No.: US08211922B2Publication Date: 2012-07-03
- Inventor: Robert Bender , Stefan Chlopicki , Jerzy Gebicki
- Applicant: Robert Bender , Stefan Chlopicki , Jerzy Gebicki
- Applicant Address: US MA Needham
- Assignee: Cortria Corporation
- Current Assignee: Cortria Corporation
- Current Assignee Address: US MA Needham
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A01N43/40
- IPC: A01N43/40 ; A01N43/16 ; A61K31/44 ; A61K31/35
Abstract:
The present invention is directed to nicotinamide derivatives, and their use in treating lipoprotein abnormalities, alone or in combination with a statin.
Public/Granted literature
- US20100120726A1 1-Methylnicotinamide Derivatives and Formulations of Treatment of Lipoprotein Abnormalities Public/Granted day:2010-05-13
Information query
IPC分类:
